Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04111185 · ClinicalTrials.gov registry record · NA
Daxor - Blood Volume Analysis
A NA study of Heart Failure and Congestive Heart Failure, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04111185 is a NA study of Heart Failure and Congestive Heart Failure that has completed, run by Duke University. The registered enrollment target is 31 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04111185, a NA study of Heart Failure and Congestive Heart Failure, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand blood volume status and whether knowledge of it can change and improve heart failure care.
Conditions Studied
Interventions
- DEVICE Receive Blood Volume Analysis Guided Treatment
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-07-16 |
| Est. Completion | 2021-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04111185
The ClinicalTrials.gov registry entry for NCT04111185 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Receive Blood Volume Analysis Guided Treatment is the first listed.
NCT04111185 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04111185 about?
NCT04111185 is a clinical study titled "Daxor - Blood Volume Analysis". The purpose of this study is to better understand blood volume status and whether knowledge of it can change and improve heart failure care.
What is the current status of trial NCT04111185?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2020-07-16. Estimated completion is 2021-09-23.
What conditions does trial NCT04111185 study?
This clinical trial studies the following conditions: Heart Failure, Congestive Heart Failure.
What interventions are being tested in trial NCT04111185?
The interventions under investigation include: Receive Blood Volume Analysis Guided Treatment (DEVICE).
Who is sponsoring clinical trial NCT04111185?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04111185 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.